Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.
ELATIVE
Show more
Class 5: Pharmaceutical preparations for the prevention and treatment of liver diseases, cholestatic diseases, metabolic diseases, cancer diseases, inflammatory diseases, autoimmune diseases and cancers; chemical preparations for medical or pharmaceutical use, namely for the prevention and treatment of liver diseases, cholestatic diseases, metabolic diseases, cancer diseases, inflammatory diseases, autoimmune diseases and cancers; organic preparations for medical or pharmaceutical use, namely for the prevention and treatment of liver diseases, cholestatic diseases, metabolic diseases, cancer diseases, inflammatory diseases, autoimmune diseases and cancers; diagnostic preparations for medical use; dia…
Class 42: Scientific research for medical purposes; pharmaceutical research and development services; conducting clinical trials for pharmaceutical products for others, in particular conducting clinical trials for determining the efficacy and safety of elafibranor; conducting clinical trials for others to determine the efficacy and safety of pharmaceutical products in the treatment of primary biliary cholangitis (PBC); conducting scientific studies and analyses in the field of pharmaceuticals and medicines; scientific research and development, namely, providing information, results and data relating to scientific or medical research and development of pharmaceutical products, via an online searchable …
Class 5 – Pharmaceuticals & supplementsClass 42 – Technology & SaaS
Status timeline
- 3 Jun 2021Application received from the International Bureau (Madrid)Sn Assigned For Sect 66a Appl From Ib
- 3 Aug 2021Assigned to an examining attorneyAssigned To Examiner
- 6 Aug 2021Office action issuedNon-Final Action Written
- 6 Dec 2021Response to office action filedTeas Response To Office Action Received
- 8 Dec 2021Approved for publicationApproved For Pub - Principal Register
- 11 Jan 2022Published for oppositionPublished For Opposition
- 29 Mar 2022Registered on the Principal RegisterRegistered-Principal Register
All 29 events
| 2025-06-19 | New Representative At Ib Received |
| 2022-09-12 | Final Decision Transaction Processed By Ib |
| 2022-08-23 | Final Disposition Processed |
| 2022-08-23 | Final Disposition Notice Sent To Ib |
| 2022-06-29 | Final Disposition Notice Created, To Be Sent To Ib |
| 2022-05-08 | New Representative At Ib Received |
| 2022-03-29 | Registered-Principal Register |
| 2022-01-11 | Published For Opposition |
| 2022-01-11 | Official Gazette Publication Confirmation E-Mailed |
| 2022-01-10 | Notification Processed By Ib |
| 2021-12-22 | Notification Of Notice Of Publication E-Mailed |
| 2021-12-22 | Notice Of Start Of Opposition Period Created, To Be Sent To Ib |
| 2021-12-22 | Notification Of Possible Opposition Sent To Ib |
| 2021-12-09 | Assigned To Lie |
| 2021-12-09 | Law Office Publication Review Completed |
| 2021-12-08 | Approved For Pub - Principal Register |
| 2021-12-06 | Teas Response To Office Action Received |
| 2021-12-06 | Correspondence Received In Law Office |
| 2021-12-06 | Teas/Email Correspondence Entered |
| 2021-09-11 | Refusal Processed By Ib |
| 2021-08-25 | Request For Reinstatement Received |
| 2021-08-25 | Non-Final Action Mailed - Refusal Sent To Ib |
| 2021-08-07 | Non-Final Action (Ib Refusal) Prepared For Review |
| 2021-08-06 | Non-Final Action Written |
| 2021-08-03 | Assigned To Examiner |
| 2021-06-12 | Application Filing Receipt Mailed |
| 2021-06-08 | New Application Office Supplied Data Entered |
| 2021-06-07 | Limitation From Original Application Entered |
| 2021-06-03 | Sn Assigned For Sect 66a Appl From Ib |
Goods & services by class
Class 5 Pharmaceuticals & supplements
Pharmaceutical preparations for the prevention and treatment of liver diseases, cholestatic diseases, metabolic diseases, cancer diseases, inflammatory diseases, autoimmune diseases and cancers; chemical preparations for medical or pharmaceutical use, namely for the prevention and treatment of liver diseases, cholestatic diseases, metabolic diseases, cancer diseases, inflammatory diseases, autoimmune diseases and cancers; organic preparations for medical or pharmaceutical use, namely for the prevention and treatment of liver diseases, cholestatic diseases, metabolic diseases, cancer diseases, inflammatory diseases, autoimmune diseases and cancers; diagnostic preparations for medical use; dia…
Class 42 Technology & SaaS
Scientific research for medical purposes; pharmaceutical research and development services; conducting clinical trials for pharmaceutical products for others, in particular conducting clinical trials for determining the efficacy and safety of elafibranor; conducting clinical trials for others to determine the efficacy and safety of pharmaceutical products in the treatment of primary biliary cholangitis (PBC); conducting scientific studies and analyses in the field of pharmaceuticals and medicines; scientific research and development, namely, providing information, results and data relating to scientific or medical research and development of pharmaceutical products, via an online searchable …
Owner details
See the official record for contact details. View official record →
Source & freshness
Source: the official United States trademark register. This record was last updated on 29 Mar 2022; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.